Nath Bio-Genes (India) balance sheet

As of Mar 2026

Total assets: ₹1,097cr+6.9% on Mar 2025
Shareholders' equity: ₹680cr+5.6% on Mar 2025
Total debt: ₹139cr+13.1% on Mar 2025
Cash and investments: ₹76.0cr−14.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	244	243	241	234
	0.0	0.0	6.0	0.0
	5.6	7.2	0.0	10.4
	5.9	5.8	8.8	5.0
	0.0	35.8	0.0	0.0
	20.6	0.0	10.9	0.0
	26.5	41.6	19.7	5.0
	42.6	44.2	42.2	22.5
	319	336	309	272
	451	338	230	208
	85.4	88.9	94.3	97.3
	76.0	88.9	77.4	38.0
	163	166	163	171
	325	344	335	306
	2.5	4.0	1.6	0.7
	779	690	572	521
	1,097	1,026	880	793
Equity
	19.0	19.0	19.0	19.0
	661	625	591	554
	680	644	610	573
	680	644	610	573
Liabilities
	17.3	13.0	0.0	0.4
	17.3	13.0	4.9	0.4
	4.9	3.5	3.0	2.8
	—	0.0	0.0	−0.0
	22.3	16.5	7.9	3.2
	121	110	105	105
	131	79.5	43.3	27.7
	140	0.0	0.0	0.0
	392	189	149	133
	0.9	0.8	0.9	0.6
	1.5	0.4	0.9	0.3
	—	175	112	83.0
	395	365	262	216
	417	382	270	220
	1,097	1,026	880	793
Assets — additional as-filed lines
	1.0	3.7	5.1	6.0
Liabilities — additional as-filed lines
	0.0	0.0	4.9	0.0
Trade payables — MSME split
	2.4	79.5	—	—
	129	0.0	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATHBIOGEN₹132.38

Nath Bio-Genes (India) Limited

· FMCG & Retail

₹ CrorePeersSARVESHWAR INDOUS SUKHJITS KOHINOOR AGRITECH REGAAL BSHSL GULPOLYMcap ₹252 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	234.0	240.6	243.2	243.8	243.8
+ Investment Property	0.0	6.0	0.0	0.0	0.0
+ Other Intangibles	10.4	0.0	7.2	5.6	5.6
+ Non-current Investments	5.0	8.8	5.8	5.9	5.9
+ Long-term Loans	0.0	0.0	35.8	0.0	0.0
+ Other Non-current Financial Assets	0.0	10.9	0.0	20.6	20.6
Non-current Financial Assets	5.0	19.7	41.6	26.5	26.5
+ Other Non-current Assets	22.5	42.2	44.2	42.6	42.6
Total Non-current Assets	272.0	308.6	336.2	318.6	318.6
Current Assets
+ Inventories	207.8	230.3	338.0	450.5	450.5
+ Trade Receivables	97.3	94.3	88.9	85.4	85.4
+ Cash & Cash Equivalents	38.0	77.4	88.9	76.0	76.0
+ Other Current Financial Assets	170.9	162.9	166.5	163.4	163.4
Current Financial Assets	306.2	334.7	344.3	324.8	324.8
+ Other Current Assets	0.7	1.6	4.0	2.5	2.5
Total Current Assets	520.8	571.7	690.0	778.9	778.9
Total Assets	792.8	880.2	1,026.2	1,097.4	1,097.4
Equity
+ Equity Share Capital	19.0	19.0	19.0	19.0	19.0
+ Other Equity / Reserves	554.2	590.9	625.4	661.5	661.5
Equity — Owners of Parent	573.2	609.9	644.4	680.5	680.5
Total Equity	573.2	609.9	644.4	680.5	680.5
Liabilities
+ Borrowings — Non-current	0.4	0.0	13.0	17.3	17.3
Non-current Financial Liabilities	0.4	4.9	13.0	17.3	17.3
+ Provisions — Non-current	2.8	3.0	3.5	4.9	4.9
+ Other Non-current Liabilities	-0.0	0.0	0.0	—	—
Non-current Liabilities	3.2	7.9	16.5	22.3	22.3
+ Borrowings — Current	104.8	105.5	109.5	121.2	121.2
+ Trade Payables	27.7	43.3	79.5	131.1	131.1
+ Other Current Financial Liab	0.0	0.0	0.0	140.1	140.1
Current Financial Liabilities	132.5	148.8	189.0	392.4	392.4
+ Provisions — Current	0.6	0.9	0.8	0.9	0.9
+ Current Tax Liabilities	0.3	0.9	0.4	1.5	1.5
+ Other Current Liabilities	83.0	111.8	175.1	—	—
Current Liabilities	216.5	262.4	365.3	394.7	394.7
Total Liabilities	219.6	270.3	381.8	417.0	417.0
Total Equity & Liabilities	792.8	880.2	1,026.2	1,097.4	1,097.4
Assets — additional as-filed lines
+ Current Tax Assets	6.0	5.1	3.7	1.0	1.0
Liabilities — additional as-filed lines
+ Trade Payables — Non-current	0.0	4.9	0.0	0.0	0.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	79.5	2.4	2.4
+ Dues to Other Creditors — Current	—	—	0.0	128.7	128.7

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.